Clinical characteristics of patients with chronic eosinophilic leukaemia (CEL) harbouring FIP1L1‐PDGFRA fusion transcript—results of Polish multicentre study
Grzegorz Helbig(Medical University of Silesia), Sławomira Kyrcz‐Krzemień(Medical University of Silesia), Magdalena Hałasz(University of Rzeszów), Marek Hus(Medical University of Lublin), Andrzej Moskwa, Justyna Gajkowska(Provincial Polyclinical Hospital in Toruń), Ilona Seferyńska, Jarosław Piszcz(Medical University of Białystok), Małgorzata Całbecka(Provincial Polyclinical Hospital in Toruń), Dariusz Woszczyk(University of Opole), Alina Świderska(University of Zielona Góra), Alina Urbanowicz, Mirosław Markiewicz(Medical University of Silesia)
Cited by 23
Related Papers
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
|New England Journal of Medicine|2024|162
Therapy‐related peripheral neuropathy in multiple myeloma patients
|Hematological Oncology|2014|70